Tackling COVID-19 with neutralizing monoclonal antibodies

D Corti, LA Purcell, G Snell, D Veesler - Cell, 2021 - cell.com
Monoclonal antibodies (mAbs) have revolutionized the treatment of several human
diseases, including cancer and autoimmunity and inflammatory conditions, and represent a …

[HTML][HTML] Rates among hospitalized patients with COVID-19 treated with convalescent plasma: a systematic review and meta-analysis

JW Senefeld, EK Gorman, PW Johnson, ME Moir… - … : Innovations, Quality & …, 2023 - Elsevier
Objective To examine the association of COVID-19 convalescent plasma transfusion with
mortality and the differences between subgroups in hospitalized patients with COVID-19 …

[HTML][HTML] Convalescent plasma treatment is associated with lower mortality and better outcomes in high-risk COVID-19 patients–propensity-score matched case-control …

A Tworek, K Jaroń, B Uszyńska-Kałuża… - International Journal of …, 2021 - Elsevier
Objective This study aimed to investigate the efficacy and safety of convalescent plasma
(CP) transfusion in a group of high-risk COVID-19 patients. Methods This prospective study …

Exercise and experiments of nature

MJ Joyner, CC Wiggins, SE Baker… - Comprehensive …, 2023 - pmc.ncbi.nlm.nih.gov
In this review we highlight the contributions of passive experiments that address important
exercise related questions in integrative physiology and medicine. Passive experiments …

Timing of convalescent plasma administration and 28-day mortality in COVID-19 pneumonia

SE González, L Regairaz, MR Salazar… - Journal of …, 2022 - journals.sagepub.com
This is a multicenter cohort study including consecutive, hospitalized patients≥ 18 years,
with moderate to severe COVID-19, carried out to evaluate the relationship between the …

Using Passive Antibody Therapies in the Next Pandemic

N Paneth, MJ Joyner, A Casadevall - 2024 - Springer
The twenty-first century has witnessed seven human viral pandemics. Approximately once
every three to four years over the past quarter-century, the world has experienced a new …

Generation and Application of SARS-CoV-2 Pseudo-typed Viral Particle System to Assess the Neutralising Ability of Sera from Mild and Severe COVID-19 Study …

K Roper - 2023 - livrepository.liverpool.ac.uk
Severe acute respiratory syndrome virus 2 (SARS-CoV-2) first emerged in Wuhan, China, at
the end of 2019 and quickly resulted in a global pandemic responsible for over seven million …